Filing Details

Accession Number:
0001181431-10-064096
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-29 19:30:39
Reporting Period:
2010-12-27
Filing Date:
2010-12-29
Accepted Time:
2010-12-29 19:30:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1128495 Anadys Pharmaceuticals Inc ANDS Pharmaceutical Preparations (2834) 223193172
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1290165 Qvt Fund Lp Walkers Spv, Walkers House
87 Mary Street
George Town, Grand Cayman E9 KY1-9005
No No Yes No
1290166 Qvt Associates Gp Llc 1177 Avenue Of The Americas
9Th Floor
New York NY 10036
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2010-12-27 1,714,210 $1.30 10,524,441 No 4 P Indirect Through QVT Fund LP and Quintessence Fund L.P.
Common Stock, $0.001 Par Value Acquisiton 2010-12-28 12,200 $1.34 10,536,641 No 4 P Indirect Through QVT Fund LP and Quintessence Fund L.P.
Common Stock, $0.001 Par Value Acquisiton 2010-12-28 532,490 $1.44 11,069,131 No 4 P Indirect Through QVT Fund LP and Quintessence Fund L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Through QVT Fund LP and Quintessence Fund L.P.
No 4 P Indirect Through QVT Fund LP and Quintessence Fund L.P.
No 4 P Indirect Through QVT Fund LP and Quintessence Fund L.P.